EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY 4.0

Bone marrow‐derived mesenchymal stem cells inhibit NK cell function via Tim‐3/galectin‐9 in multiple myeloma patients

Zhao-Yun Liu, Nan-Hao Meng iD, Pan-Pan Cao, Yue Jia iD, Hao Wang, Yun-He Zhang, Hui Liu, Rong Fu iD

Clinical and Translational Medicine · 2023

DOI: 10.1002/ctm2.1224 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Clinical and Translational Medicine, 2023. Verfasst von Zhao-Yun Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Tianjin Medical University General Hospital, Heping District, Tianjin, People's Republic of China. Hauptthemen laut MEDLINE: Multiple Myeloma, Mesenchymal Stem Cells. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China Youth Project, Tianjin Municipal Natural Science Foundation, Tianjin Education Commission Research Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaMesenchymal Stem CellsHumansHepatitis A Virus Cellular Receptor 2Bone MarrowKiller Cells, NaturalGalectins

Substanzen

Hepatitis A Virus Cellular Receptor 2Galectins

Autor:innen und Institutionen

  • Department of Hematology, Tianjin Medical University General Hospital, Heping District, Tianjin, People's Republic of China.

ORCID-Profile: Nan-Hao Meng, Yue Jia, Rong Fu

Förderung

  • National Natural Science Foundation of China Youth Project
  • Tianjin Municipal Natural Science Foundation
  • Tianjin Education Commission Research Project
  • Tianjin Science and Technology Planning Project
  • Tianjin Municipal Health Commission Youth Project
  • Medjaden Academy & Research Foundation for Young Scientists
  • Tianjin Key Medical Discipline(Specialty) Construction Project

Zitieren

APA

Liu, Z. Y., Meng, N. H., Cao, P. P., Jia, Y., Wang, H., Zhang, Y. H., Liu, H., & Fu, R. (2023). Bone marrow‐derived mesenchymal stem cells inhibit NK cell function via Tim‐3/galectin‐9 in multiple myeloma patients. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.1224

Vancouver

Liu ZY, Meng NH, Cao PP, Jia Y, Wang H, Zhang YH, et al. Bone marrow‐derived mesenchymal stem cells inhibit NK cell function via Tim‐3/galectin‐9 in multiple myeloma patients. Clinical and Translational Medicine. 2023. doi:10.1002/ctm2.1224

BibTeX
@article{Liu2023,
  author = {Liu, Zhao-Yun and Meng, Nan-Hao and Cao, Pan-Pan and Jia, Yue and Wang, Hao and Zhang, Yun-He and Liu, Hui and Fu, Rong},
  title = {Bone marrow‐derived mesenchymal stem cells inhibit NK cell function via Tim‐3/galectin‐9 in multiple myeloma patients},
  journal = {Clinical and Translational Medicine},
  year = {2023},
  doi = {10.1002/ctm2.1224}
}
Kostenlos starten →